Drug intelligence / Profile preview

Meilian Fuxin Solution

Development stage
Phase 3
Lead developer
West China Hospital of Sichuan University
Administration
Topical
01

Overview

Meilian Fuxin Solution is a topical regenerative formulation derived from the extract of *Periplaneta americana* (the American cockroach). Developed and studied by West China Hospital, it is primarily indicated for the prevention and treatment of radiation dermatitis in patients undergoing radiotherapy, such as those with head and neck squamous cell carcinoma. The solution contains a complex mixture of bioactive components, including amino acids, peptides, and polyols, which are thought to promote wound healing by stimulating the growth of granulation tissue, enhancing angiogenesis, and providing anti-inflammatory effects. It is typically applied topically to the affected skin areas to accelerate tissue repair and mitigate the severity of radiation-induced skin damage.

Brand names
Meilian Fuxin SolutionMeilian Fuxin Liquid
Other names
Periplaneta americana-derived Meilian Fuxin SolutionPeriplaneta americana-derived regenerative solution

Beyond the preview

Go deeper on Meilian Fuxin Solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meilian Fuxin Solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call